Where can the investigational product be supplied or dispensed?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

In Good Clinical Practice, how the investigational product is distributed is about ensuring proper control, traceability, storage, and access for the participant. The IP isn’t limited to the sponsor’s site or a central warehouse; it can be delivered to the participant’s location, to a local pharmacy, or to a local healthcare center. This arrangement supports convenient dosing, supervised administration when needed, and clear accountability through appropriate records and documentation, while still maintaining required storage conditions and regulatory compliance. Direct-to-patient shipments or local dispensing are common when the protocol and regulatory requirements permit them and the monitoring and handling plans are in place. Limiting supply to only the sponsor site or only to a central warehouse would add unnecessary barriers and isn’t as flexible as the allowed distribution paths described.